Latest filing published 05 Sept 2017 for ALBANY MOLECULAR RESEARCH INC, €2.4M.
Insider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
George Svokos: trading record in brief
This profile gathers the share dealings of George Svokos in Albany Molecular Research Inc. The record holds 26 filings, for trades running from 4 February 2014 to 31 August 2017.
Purchases make up the whole of the open-market record (3 purchases, €418k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 22 share grants.
Half of the purchases are above €141k and half below.
On 5 September 2017 came the latest disclosure, a transaction for €2.4M in Albany Molecular Research Inc. The clock since the last published purchase (16 May 2016) now reads 3,828 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to George Svokos
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 129,150 shares@ US$21.7588.0% of flowCommon StockSEC:0001638599-17-000868:1
- 6,064 shares0Common StockSEC:0001638599-17-000868:0
- 1,324 shares@ US$16.040.7% of flowCommon StockSEC:0001638599-17-000688:0
- 361 shares@ US$14.520.2% of flowCommon StockSEC:0001144204-17-012949:0
- 11,543 shares0Common StockSEC:0001638599-17-000183:0
- 8,663 shares0Common StockSEC:0001638599-17-000183:1
- 2,381 shares@ US$18.521.5% of flowCommon StockSEC:0001638599-17-000157:0
- 596 shares@ US$18.520.4% of flowCommon StockSEC:0001638599-17-000157:1
- 751 shares@ US$18.520.5% of flowCommon StockSEC:0001638599-17-000157:2
- 3,535 shares@ US$18.982.4% of flowCommon StockSEC:0001638599-17-000049:0
- 817 shares@ US$15.090.4% of flowCommon StockSEC:0001638599-16-001482:0
- 1,312 shares@ US$11.420.5% of flowCommon StockSEC:0001638599-16-001157:0
- 12,500 shares@ US$12.825.3% of flowCommon StockSEC:0001638599-16-000880:0Canonical exit: 11 Aug 2016 (T+90)
- 361 shares@ US$15.330.2% of flowCommon StockSEC:0001638599-16-000720:0
- 18,390 sharesCommon StockSEC:0001638599-16-000622:0
- 58 sharesCommon StockSEC:0001638599-16-000610:0
- 596 sharesCommon StockSEC:0001638599-16-000610:1
- 3,499 sharesCommon StockSEC:0001638599-16-000490:0
- 10,000 shares@ US$19.16Common StockSEC:0001638599-15-000286:0
- 10,000 shares@ US$17.72Common StockSEC:0001179110-15-004730:0Canonical exit: 8 Jun 2015 (T+90)
- 8,824 shares@ US$17.05Common StockSEC:0001179110-15-004212:0
- 596 shares0Common StockSEC:0001179110-15-001998:0
- 1,445 shares@ US$13.84Common StockSEC:0001179110-15-001998:1
- 3,584 shares@ US$14.84Common StockSEC:0001179110-15-000691:0
- 10,000 shares@ US$15.60Common StockSEC:0001179110-14-008561:0Canonical exit: 13 Aug 2014 (T+90)
25 of 25 declarations